文献速递免疫规划

猪霍乱沙门菌减毒突变株作为潜在减毒活疫苗的构建与评价

Generation and evaluation of Salmonella entericaserovar Choleraesuis mutant strains as a potential live-attenuated vaccine.
PubMed 文献 · Vaccine · 2024-08-27

研究用CRISPR-Cas9技术敲除猪霍乱沙门菌的毒力调控基因rpoS和slyA,构建∆rpoS、∆slyA及∆rpoS ∆slyA三株突变株。突变株表型与亲本野生株相比未发生变化;小鼠体内∆slyA与∆rpoS ∆slyA株减轻脾肿大、结肠萎缩及脾、肝、回肠、结肠的细菌载量,并在派尔集合淋巴结和肠系膜淋巴结存活至感染后15天。∆rpoS ∆slyA株免疫诱导强烈的体液和细胞免疫应答,并对致死性侵袭性沙门菌(猪霍乱沙门菌)提供高比例保护。

要点

  • CRISPR-Cas9敲除rpoS、slyA构建猪霍乱沙门菌减毒株,表型与野生株相比未变
  • ∆slyA与∆rpoS ∆slyA株减轻小鼠脾肿大、结肠萎缩并降低组织细菌载量
  • ∆rpoS ∆slyA免疫诱导体液和细胞免疫,对致死性侵袭性猪霍乱沙门菌提供高比例保护

核心结论

  • ∆rpoS ∆slyA株免疫对小鼠致死性侵袭性猪霍乱沙门菌感染提供高比例保护,为猪霍乱沙门菌减毒活疫苗研发提供新思路。

研究设计与样本

  • 用CRISPR-Cas9技术敲除猪霍乱沙门菌毒力调控基因rpoS和slyA,构建∆rpoS、∆slyA和∆rpoS ∆slyA三株突变株,并开展体内研究。

主要发现

  • 突变株表型特征与亲本野生型株相比保持不变。
  • 与野生型株不同,∆slyA和∆rpoS ∆slyA株减轻脾肿大、结肠萎缩,并降低脾、肝、回肠和结肠的细菌载量。
  • 上述突变株在派尔集合淋巴结和肠系膜淋巴结中存活至感染后15天。
  • ∆rpoS ∆slyA株免疫诱导强烈的体液和细胞免疫应答。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Salmonella entericaserovar Choleraesuis (S.C) is a swine enteric pathogen causing paratyphoid fever, enterocolitis, and septicemia in piglets. S. C is mainly transmitted through the fecal-oral route. Vaccination is an effective strategy for preventing and controlling Salmonella infection. RESULTS: Herein, we used CRISPR-Cas9 technology to knockout the virulence regulatory genes, rpoS, and slyA of S. C and constructed the ∆rpoS, ∆slyA, and ∆rpoS ∆slyA strains. The phenotypic characteristics of the mutant strains remained unchanged compared with the parental wild-type strain. In vivo study, unlike the wild-type strain, the ∆slyA and ∆rpoS ∆slyA strains alleviated splenomegaly, colon atrophy, and lower bacterial loads in the spleen, liver, ileum, and colon. These mutant strains survived in Peyer's patches (PPs) and mesenteric lymph nodes (MLN) for up to 15 days post-infection. Furthermore, the immunization of the ∆rpoS ∆slyA strain induced robust humoral and cellular immune responses. CONCLUSIONS: Consequently, vaccination with ∆rpoS ∆slyA conferred a high percentage of protection against lethal invasive Salmonella, specifically S. C, in mice. This study provided novel insights into the development of live-attenuated vaccines against the infection of S. C.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Huang X, Yang S, Zhao J, et al. Generation and evaluation of Salmonella entericaserovar Choleraesuis mutant strains as a potential live-attenuated vaccine. Vaccine. 2024. PMID: 39197218. doi:10.1016/j.vaccine.2024.126262

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。